Search | IOVS | ARVO Journals

View

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Drug Retention Rate of Tocilizumab in Uveitis. Real-World Data from the Spanish Biotherapies in Uveitis (BioÚvea) Study Group

Alfredo Adan Civera; Victor Llorens; Miguel Cordero-Coma; Lucía Martínez-Costa; Ana Blanco-Esteban; Maria-Jose Losada-Castillo; Cristina Hernando-Hernandez; Enrique Judez-Navarro; Angel Garcia-Aparicio; Luis Rodriguez Melian; Margarita Jodar-Marquez; Olga Garcia Garcia; Alejandro Fonollosa-Calduch; Lidia Cocho; Jorge Solana-Fajardo; Marisa Hernandez-Garfella

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3516. doi:

ARVO Annual Meeting Abstract July 2019

Drug Retention Rate of Adalimumab in Uveitis. Real-World Data from the Spanish Biotherapies in Uveitis (BioÚvea) Study Group.

Victor Llorens; Miguel Cordero-Coma; Ana Blanco-Esteban; Henar Heras-Mulero; María-José Losada-Castillo; Vega Jovani-Casano; Lucía Martínez-Costa; Margarita Jodar-Marquez; Ángel-María Garcia-Aparicio; Alejandro Fonollosa-Calduch; Cristina Hernando-Hernandez; Luís Rodriguez-Melian; Manuel Fernandez-Prada; María Jerez-Fidalgo; Marisa Hernandez-Garfella; Alfredo Adan

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3855. doi:

ARVO Annual Meeting Abstract June 2017

Comparing Prednisone and Methotrexate to Off-label Infliximab for the Management of Posterior Uveitis and Panuveitis: A Cost-Effectiveness Analysis

William V Padula; Taygan Yilmaz; Miguel Cordero-Coma; Michéal J Gallagher; Michael E Migliori

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):509. doi:

ARVO Annual Meeting Abstract June 2017

Discontinuation and Nonpublication of Interventional Clinical Trials Conducted in Uveitis Patients

Taygan Yilmaz; Miguel Cordero-Coma; Michael E Migliori

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2186. doi:

ARVO Annual Meeting Abstract June 2013

Multicenter study of TNF-a antagonists for refractory Behçet’s uveitis in Spain

Marina Mesquida; David Diaz-Valle; Miguel Cordero Coma; Alejandro Fonollosa; Victor Llorens; Laura Pelegrin; Maria Victoria Hernandez; Gerard Espinosa; Blanca Molins; Alfredo Adan Civera

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5192. doi:

ARVO Annual Meeting Abstract March 2012

High Dose Intravenous Methylprednisolone Induces Rapid Improvement In Severe Uveitis: A Multicenter Study

Miguel Cordero Coma; Ricardo Blanco; Carmen Bejerano; Emma Beltrán; Alex Fonollosa; Olga Maiz; Ana Blanco; Joaquin Cañal; Juan Ventosa; Miguel Angel Gonzalez Gay

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1182. doi:

ARVO Annual Meeting Abstract April 2011

Efficacy of Combined Cyclosporine A and Mycophenolate Mofetil in the Treatment of Patients with Birdshot Retinochoroidopathy: A 12-month follow-up

Luis A. Gonzalez; Rene A. Cervantes-Castañeda; Miguel Cordero Coma; Taygan Yilmaz; C Stephen Foster

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4263. doi:

ARVO Annual Meeting Abstract April 2010

To Determine the Influence of Geographic Location and Insurance Status on the Likelihood of Receiving a Diagnosis of Cataract

M. J. Gallagher; T. Yilmaz; W. Padula; M. Cordero-Coma; R. Macdonell

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4555. doi:

ARVO Annual Meeting Abstract April 2010

Use of Control Charts to Monitor Post-Cataract Surgery Acute Endophthalmitis in Spain

M. Cordero Coma; T. Yilmaz; M. Gallagher; E. Rodríguez García; S. Lanier; W. V. Padula; D. Kim; K. Guja; C. Weaver; M. Mishra

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5426. doi:

ARVO Annual Meeting Abstract May 2008

Intravitreal Triamcinolone Acetonide for the Treatment of Refractory Diabetic Macular Edema: An Evidence-Based Systematic Review

T. Yilmaz; C. Weaver; M. Cordero-Coma; M. J. Gallagher; R. A. Cervantes-Castaneda; R. J. Larson

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3487. doi:

Advertisement